Risk factors for early mortality and morbidity after pneumonectomy

Basit Öğe Kaydı
dc.authoridkaramustafaoglu, yekta altemur/0000-0002-5491-1219
dc.authoridBaysal, AyG/0000-0002-1487-7407
dc.authoridYORUK, YENER/0000-0001-6309-3054
dc.authoridsagiroglu, gonul/0000-0002-1189-4973
dc.authorwosidSagiroglu, Gonul/ABH-1345-2021
dc.authorwosidYoruk, Yener/W-4285-2017
dc.authorwosidBaysal, Ayse/AAR-8769-2021
dc.authorwosidkaramustafaoglu, yekta altemur/S-9512-2019
dc.authorwosidsagiroglu, gönül/AAB-4472-2021
dc.authorwosidBaysal, AyG/AAR-8763-2021
dc.authorwosidBaysal, Ayse/AAF-8294-2019
dc.contributor.authorSagiroglu, Gonul
dc.contributor.authorCopuroglu, Elif
dc.contributor.authorMeydan, Burhan
dc.contributor.authorTasci, Erdal
dc.contributor.authorKaramustafaoglu, Y. Altemur
dc.contributor.authorBaysal, Ayse
dc.contributor.authorYoruk, Yener
dc.date.accessioned2024-06-12T11:08:42Z
dc.date.available2024-06-12T11:08:42Z
dc.date.issued2014
dc.departmentTrakya Üniversitesien_US
dc.description.abstractBackground: This study aims to investigate possible risk factors which affect the mortality and morbidity of pneumonectomy patients due to the non-small cell lung cancer (NSCLC). Methods: Demographic, clinical and pathological features of 100 patients (96 males, 4 females; mean age 58.4 +/- 8.9 years; range 38 to 82 years) who underwent pneumonectomy between April 2008 and October 2009 were retrospectively analyzed. Results: The morbidity and mortality rates were found to be 56% and 14%, respectively. The complications included cardiopulmonary in 46%, bleeding in 7%, and wound infection in 3% patients. There was no significant effect of age, sex, smoking habit, diabetes, hypertension, and coronary artery disease on 30-day morbidity and mortality. Neoadjuvant therapy (p=0.049), right pneumonectomy (p=0.01), and intraoperative blood transfusion (p=0.049) were associated with significantly increased morbidity. The duration of intensive care unit and hospital stays was significantly longer in patients with respiratory failure and bronchopleural fistula. Conclusion: Pneumonectomy is a high-risk procedure in patients with neoadjuvant therapy, right pneumonectomy, and intraoperative blood transfusion. However, we believe that it is possible to reduce the risk factors with careful preoperative evaluation, rigorous anesthetic assessment and surgical interventions.en_US
dc.identifier.doi10.5606/tgkdc.dergisi.2014.8696
dc.identifier.endpage375en_US
dc.identifier.issn1301-5680
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-84899759632en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage368en_US
dc.identifier.trdizinid221484en_US
dc.identifier.urihttps://doi.org/10.5606/tgkdc.dergisi.2014.8696
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/221484
dc.identifier.urihttps://hdl.handle.net/20.500.14551/22536
dc.identifier.volume22en_US
dc.identifier.wosWOS:000334902700020en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherBaycinar Medical Publ-Baycinar Tibbi Yayinciliken_US
dc.relation.ispartofTurk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal Of Thoracic And Cardiovascular Surgeryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMorbidityen_US
dc.subjectMortalityen_US
dc.subjectPneumonectomyen_US
dc.subjectCell Lung-Canceren_US
dc.subjectRandomized Controlled-Trialen_US
dc.subjectCompletion Pneumonectomyen_US
dc.subjectOperative Mortalityen_US
dc.subjectComplicationsen_US
dc.subjectChemotherapyen_US
dc.subjectRadiotherapyen_US
dc.subjectResectionen_US
dc.subjectSurgeryen_US
dc.subjectTherapyen_US
dc.titleRisk factors for early mortality and morbidity after pneumonectomyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu